Tobacco Tactics Website for Operating Engineers (BCBSM-OE)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Blue Cross Blue Shield of Michigan Foundation
Information provided by (Responsible Party):
Sonia Duffy, University of Michigan
ClinicalTrials.gov Identifier:
NCT01124110
First received: May 13, 2010
Last updated: November 26, 2013
Last verified: November 2013

May 13, 2010
November 26, 2013
January 2010
March 2013   (final data collection date for primary outcome measure)
  • Quit Rate [ Time Frame: 30-day Follow-Up ] [ Designated as safety issue: No ]
    The investigators will measure 7-day point prevalence abstinence by asking the well validated question, "Have you used any tobacco products (even one puff) in the past 7 days?" The investigators will also assess harm reduction (ability to quit at all, number of quit attempts, and number of cigarettes smoked per day).
  • Quit Rate [ Time Frame: 6-Month Follow-Up ] [ Designated as safety issue: No ]
    The investigators will measure 7-day point prevalence abstinence by asking the well validated question, "Have you used any tobacco products (even one puff) in the past 7 days?" Smoking status will be confirmed by biochemical verification in the form of urinary cotinine test strips. The investigators will also assess harm reduction (ability to quit at all, number of quit attempts, and number of cigarettes smoked per day).
  • Quit Rate [ Time Frame: 30-day Follow-Up ] [ Designated as safety issue: No ]
    We will measure 7-day point prevalence abstinence by asking the well validated question, "Have you used any tobacco products (even one puff) in the past 7 days?" We will also assess harm reduction (ability to quit at all, number of quit attempts, and number of cigarettes smoked per day).
  • Quit Rate [ Time Frame: 6-Month Follow-Up ] [ Designated as safety issue: No ]
    We will measure 7-day point prevalence abstinence by asking the well validated question, "Have you used any tobacco products (even one puff) in the past 7 days?" Smoking status will be confirmed by biochemical verification in the form of urinary cotinine test strips. We will also assess harm reduction (ability to quit at all, number of quit attempts, and number of cigarettes smoked per day).
Complete list of historical versions of study NCT01124110 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Tobacco Tactics Website for Operating Engineers
Tobacco Tactics Website for Operating Engineers

This is a clustered randomized control trial to test the Tobacco Tactics intervention among Operating Engineers (heavy equipment workers). The intervention group will be directed to the Tobacco Tactics website, and the control group will be directed to the state supported 1-800 quit-now telephone hotline during routine annual safety training that all Operating Engineers are required to attend. The web-based quitting intervention includes provision of over-the-counter nicotine replacement therapy and will be followed by nurse email and/or telephone counseling. It is expected that Operating Engineers who are randomized to the Tobacco Tactics website intervention will have at least equal or greater decreases in smoking at 30-day and 6-month follow-up compared to those randomized to the 1-800-QUIT-NOW quit line. In addition, the investigators expect to find that Operating Engineers randomized to the Tobacco Tactics website intervention will: a) be able to accomplish tasks; b) be able to accomplish goals with skill and speed; c) be able to operate the system; d) be satisfied with the website; e) access the site repeatedly; and f) spend time on the site during the intervention period.

Not Provided
Interventional
Phase 3
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
  • Smoking
  • Tobacco Use Cessation
  • Behavioral: Tobacco Tactics Web-Based Intervention
    The Tobacco Tactics Web-Based Intervention contains website, medications, and nurse counseling.
  • Other: 1-800-QUIT-NOW Telephone Hotline
    The control group receives efficacious smoking cessation treatment via the 1-800-QUIT-NOW telephone hotline. The 1-800-QUIT-NOW hotline is a national program. The first time smokers call the hotline, they receive a personal coach who assists them in setting a quit date and making an individualized quit plan. The personal coach also provides on-going support with up to five telephone coaching sessions around the caller's quit date.
  • 1-800-QUIT-NOW Telephone Hotline
    The control group receives efficacious smoking cessation treatment via the 1-800-QUIT-NOW telephone hotline. The 1-800-QUIT-NOW hotline is a national program. The first time smokers call the hotline, they receive a personal coach who assists them in setting a quit date and making an individualized quit plan. The personal coach also provides on-going support with up to five telephone coaching sessions around the caller's quit date.
    Intervention: Other: 1-800-QUIT-NOW Telephone Hotline
  • Experimental: Tobacco Tactics Intervention
    This intervention contains a website, medications, and nurse counseling.
    Intervention: Behavioral: Tobacco Tactics Web-Based Intervention

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
100
August 2014
March 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • attending a training session provided by the Operating Engineers Local 324 Education Center
  • greater than 18 years of age
  • smoked cigarettes in the past month
  • interested in participating in a program to quit smoking
Both
18 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01124110
N011646 - 1465.RFP
No
Sonia Duffy, University of Michigan
University of Michigan
Blue Cross Blue Shield of Michigan Foundation
Principal Investigator: Sonia A Duffy, PhD, RN University of Michigan
University of Michigan
November 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP